NCT01565343 A Study of 18F-AV-45 in Alzheimer's Disease (AD) and Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01561430 Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease Status TERMINATED Phase PHASE1/PHASE2
NCT01561053 A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease Status COMPLETED Phase PHASE2/PHASE3
NCT01560585 Open Label Study of Isotretinoin in Mild to Moderate Alzheimer's Disease Status TERMINATED Phase PHASE1/PHASE2
NCT01559220 Deep Brain Stimulation for the Treatment of Alzheimer's Disease Status COMPLETED Phase NA
NCT01553929 Physical Training and Cognitive Activity on the Mild Cognitive Impairment (MCI) Patient Status TERMINATED Phase NA
NCT01549834 Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors Status COMPLETED Phase PHASE2
NCT01548430 A Safety Study of TTP4000 in Subjects With Alzheimer's Disease Status COMPLETED Phase PHASE1
NCT01547689 Safety and Efficiency of Umbilical Cord-derived Mesenchymal Stem Cells(UC-MSC) in Patients With Alzheimer's Disease Status UNKNOWN Phase PHASE1/PHASE2
NCT01547169 Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 21 Days Status COMPLETED Phase PHASE2
NCT01538212 Retrospective Cohort Study Of The Efficacy Of Axona® (Medium Chain Triglycerides) In Patients With Alzheimer's Disease Status COMPLETED Phase N/A
NCT01537757 A Two-Part, Single-Dose Study of the Pharmacokinetics of MK-8931 in Subjects With Renal Insufficiency (MK-8931-009 [P08535]) Status COMPLETED Phase PHASE1
NCT01529619 Efficacy, Safety and Tolerability of Rivastigmine Patch in Patients With Mild to Moderate Alzheimer's Disease Switched From Cholinesterase Inhibitors Status COMPLETED Phase PHASE4
NCT01527916 Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease Status COMPLETED Phase PHASE2